Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))

Yuya Matsue; Makoto Suzuki; Sho Torii; Satoshi Yamaguchi; Seiji Fukamizu; Yuichi Ono; Hiroyuki Fujii; Takeshi Kitai; Toshihiko Nishioka; Kaoru Sugi; Yuko Onishi; Makoto Noda; Nobuyuki Kagiyama; Yasuhiro Satoh; Kazuki Yoshida; Steven R. Goldsmith

doi:10.1016/j.cardfail.2016.07.434

Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))

Yuya Matsue, Makoto Suzuki, Sho Torii, Satoshi Yamaguchi, Seiji Fukamizu, Yuichi Ono, Hiroyuki Fujii, Takeshi Kitai, Toshihiko Nishioka, Kaoru Sugi, Yuko Onishi, Makoto Noda, Nobuyuki Kagiyama, Yasuhiro Satoh, Kazuki Yoshida, Steven R. Goldsmith

Medicine - Cardiology Division

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Abstract

The authors regret that on page 429, in the Discussion section of the Aquamarine trial, the ASCEND trial is incorrectly described. The actual title is ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). The reference (21) is correct. Also on page 429, the RELAX-AHF trial is incorrectly cited. The correct trial referred to is PROTECT. Reference 22 should be: Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, et al, PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010;363:1419-28. The authors apologize for any inconvenience caused.

Original language	English (US)
Pages (from-to)	941
Number of pages	1
Journal	Journal of cardiac failure
Volume	22
Issue number	11
DOIs	https://doi.org/10.1016/j.cardfail.2016.07.434
State	Published - Nov 1 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.

Publisher link

10.1016/j.cardfail.2016.07.434

Find It

Find It at U of M Libraries

Fingerprint

Dive into the research topics of 'Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))'. Together they form a unique fingerprint.

Cite this

Matsue, Y., Suzuki, M., Torii, S., Yamaguchi, S., Fukamizu, S., Ono, Y., Fujii, H., Kitai, T., Nishioka, T., Sugi, K., Onishi, Y., Noda, M., Kagiyama, N., Satoh, Y., Yoshida, K., & Goldsmith, S. R. (2016). Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007)). Journal of cardiac failure, 22(11), 941. https://doi.org/10.1016/j.cardfail.2016.07.434

Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007)). / Matsue, Yuya; Suzuki, Makoto; Torii, Sho et al.
In: Journal of cardiac failure, Vol. 22, No. 11, 01.11.2016, p. 941.

Research output: Contribution to journal › Comment/debate › peer-review

Matsue, Y, Suzuki, M, Torii, S, Yamaguchi, S, Fukamizu, S, Ono, Y, Fujii, H, Kitai, T, Nishioka, T, Sugi, K, Onishi, Y, Noda, M, Kagiyama, N, Satoh, Y, Yoshida, K & Goldsmith, SR 2016, 'Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))', Journal of cardiac failure, vol. 22, no. 11, pp. 941. https://doi.org/10.1016/j.cardfail.2016.07.434

Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y et al. Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007)). Journal of cardiac failure. 2016 Nov 1;22(11):941. doi: 10.1016/j.cardfail.2016.07.434

@article{d066b0f101e84d8b84804485f7c01342,

title = "Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))",

abstract = "The authors regret that on page 429, in the Discussion section of the Aquamarine trial, the ASCEND trial is incorrectly described. The actual title is ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). The reference (21) is correct. Also on page 429, the RELAX-AHF trial is incorrectly cited. The correct trial referred to is PROTECT. Reference 22 should be: Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, et al, PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010;363:1419-28. The authors apologize for any inconvenience caused.",

author = "Yuya Matsue and Makoto Suzuki and Sho Torii and Satoshi Yamaguchi and Seiji Fukamizu and Yuichi Ono and Hiroyuki Fujii and Takeshi Kitai and Toshihiko Nishioka and Kaoru Sugi and Yuko Onishi and Makoto Noda and Nobuyuki Kagiyama and Yasuhiro Satoh and Kazuki Yoshida and Goldsmith, {Steven R.}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.cardfail.2016.07.434",

language = "English (US)",

volume = "22",

pages = "941",

journal = "Journal of cardiac failure",

issn = "1071-9164",

publisher = "Elsevier B.V.",

number = "11",

}

TY - JOUR

T1 - Erratum

T2 - Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))

AU - Matsue, Yuya

AU - Suzuki, Makoto

AU - Torii, Sho

AU - Yamaguchi, Satoshi

AU - Fukamizu, Seiji

AU - Ono, Yuichi

AU - Fujii, Hiroyuki

AU - Kitai, Takeshi

AU - Nishioka, Toshihiko

AU - Sugi, Kaoru

AU - Onishi, Yuko

AU - Noda, Makoto

AU - Kagiyama, Nobuyuki

AU - Satoh, Yasuhiro

AU - Yoshida, Kazuki

AU - Goldsmith, Steven R.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - The authors regret that on page 429, in the Discussion section of the Aquamarine trial, the ASCEND trial is incorrectly described. The actual title is ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). The reference (21) is correct. Also on page 429, the RELAX-AHF trial is incorrectly cited. The correct trial referred to is PROTECT. Reference 22 should be: Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, et al, PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010;363:1419-28. The authors apologize for any inconvenience caused.

AB - The authors regret that on page 429, in the Discussion section of the Aquamarine trial, the ASCEND trial is incorrectly described. The actual title is ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). The reference (21) is correct. Also on page 429, the RELAX-AHF trial is incorrectly cited. The correct trial referred to is PROTECT. Reference 22 should be: Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, et al, PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med 2010;363:1419-28. The authors apologize for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=84979782558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979782558&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2016.07.434

DO - 10.1016/j.cardfail.2016.07.434

M3 - Comment/debate

C2 - 27481596

AN - SCOPUS:84979782558

SN - 1071-9164

VL - 22

SP - 941

JO - Journal of cardiac failure

JF - Journal of cardiac failure

IS - 11

ER -

Erratum: Corrigendum to “Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction” (Journal of Cardiac Failure (2016) 22(6) (423–432)(S1071916416000671)(10.1016/j.cardfail.2016.02.007))

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

Cite this